BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25180912)

  • 1. LRIG and cancer prognosis.
    Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
    Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
    Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
    Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
    Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
    Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
    Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
    Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.
    Del Rio T; Nishitani AM; Yu WM; Goodrich LV
    PLoS Genet; 2013; 9(9):e1003824. PubMed ID: 24086156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.
    Ghasimi S; Haapasalo H; Eray M; Korhonen K; Brännström T; Hedman H; Andersson U
    J Neurooncol; 2012 Jul; 108(3):435-41. PubMed ID: 22484910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers.
    Malik U; Javed A
    Curr Cancer Drug Targets; 2017; 17(1):3-16. PubMed ID: 27628597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
    Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
    Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.
    Ranhem C; Lillsunde Larsson G; Hedman H; Lindquist D; Karlsson MG; Hellström AC; Östensson E; Sorbe B; Hellman K; Andersson S
    PLoS One; 2017; 12(8):e0183816. PubMed ID: 28841699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
    Guo D; Han L; Shu K; Chen J; Lei T
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LRIG family: enigmatic regulators of growth factor receptor signaling.
    Simion C; Cedano-Prieto ME; Sweeney C
    Endocr Relat Cancer; 2014; 21(6):R431-43. PubMed ID: 25183430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications.
    Mao F; Wang B; Xiao Q; Cheng F; Lei T; Guo D
    J Neurol Sci; 2017 Dec; 383():56-60. PubMed ID: 29246624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
    Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C
    J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lrig2-deficient mice are protected against PDGFB-induced glioma.
    Rondahl V; Holmlund C; Karlsson T; Wang B; Faraz M; Henriksson R; Hedman H
    PLoS One; 2013; 8(9):e73635. PubMed ID: 24023893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.
    Wu X; Hedman H; Bergqvist M; Bergström S; Henriksson R; Gullbo J; Lennartsson J; Hesselius P; Ekman S
    Acta Oncol; 2012 Jan; 51(1):69-76. PubMed ID: 21417672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
    Herdenberg C; Hedman H
    Stem Cell Rev Rep; 2023 Jan; 19(1):59-66. PubMed ID: 35969315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome.
    Lindström AK; Hellberg D
    Eur J Histochem; 2014 Apr; 58(2):2227. PubMed ID: 24998916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.
    Holmlund C; Haapasalo H; Yi W; Raheem O; Brännström T; Bragge H; Henriksson R; Hedman H
    Neuropathology; 2009 Jun; 29(3):242-7. PubMed ID: 18992012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-specific regulation of transforming growth factor beta superfamily factors by leucine-rich repeats and immunoglobulin-like domains proteins.
    Abdullah A; Herdenberg C; Hedman H
    PLoS One; 2023; 18(8):e0289726. PubMed ID: 37603563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.